My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9.

    Dandona P, Aljada A, Mohanty P, Ghanim H, Bandyopadhyay A, Chaudhuri A.

    Diabetes Care. 2003 Dec;26(12):3310-4.PMID: 14633819 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

    Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S.

    J Clin Endocrinol Metab. 2001 Jul;86(7):3257-65.PMID: 11443198 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations.

    Aljada A, Ghanim H, Mohanty P, Kapur N, Dandona P.

    J Clin Endocrinol Metab. 2002 Mar;87(3):1419-22.PMID: 11889219 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Growth hormone replacement decreases plasma levels of matrix metalloproteinases (2 and 9) and vascular endothelial growth factor in growth hormone-deficient individuals.

    Randeva HS, Lewandowski KC, Komorowski J, Murray RD, O'Callaghan CJ, Hillhouse EW, Stepien H, Shalet SM.

    Circulation. 2004 May 25;109(20):2405-10. Epub 2004 May 3.PMID: 15123527 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effect of modified glucose-insulin-potassium on free fatty acids, matrix metalloproteinase, and myoglobin in ST-elevation myocardial infarction.

    Chaudhuri A, Janicke D, Wilson M, Ghanim H, Wilding GE, Aljada A, Dandona P.

    Am J Cardiol. 2007 Dec 1;100(11):1614-8.PMID: 18036357 [PubMed - indexed for MEDLINE]Related articles

    6.

    Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects.

    Miyazawa-Hoshimoto S, Takahashi K, Bujo H, Hashimoto N, Saito Y.

    Diabetologia. 2003 Nov;46(11):1483-8. Epub 2003 Oct 8.PMID: 14534780 [PubMed - indexed for MEDLINE]Related articles

    7.

    Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations.

    Aljada A, Ghanim H, Mohanty P, Syed T, Bandyopadhyay A, Dandona P.

    Am J Clin Nutr. 2004 Jul;80(1):51-7.PMID: 15213027 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegaly.

    Paisley AN, O'Callaghan CJ, Lewandowski KC, Parkinson C, Roberts ME, Drake WM, Monson JP, Trainer PJ, Randeva HS.

    J Clin Endocrinol Metab. 2006 Nov;91(11):4635-40. Epub 2006 Aug 22.PMID: 16926249 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.

    Tamura M, Oda M, Matsumoto I, Tsunezuka Y, Kawakami K, Ohta Y, Watanabe G.

    Ann Surg Oncol. 2004 Oct;11(10):928-33. Epub 2004 Sep 20.PMID: 15383417 [PubMed - indexed for MEDLINE]Related articles

    10.

    Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy.

    Ishizaki E, Takai S, Ueki M, Maeno T, Maruichi M, Sugiyama T, Oku H, Ikeda T, Miyazaki M.

    Am J Ophthalmol. 2006 Jan;141(1):129-134.PMID: 16386986 [PubMed - indexed for MEDLINE]Related articles

    11.

    Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma.

    Alexandrakis MG, Sfiridaki A, Miyakis S, Pappa C, Kandidaki E, Alegakis A, Margioris AN.

    Clin Chim Acta. 2007 Apr;379(1-2):31-5. Epub 2006 Dec 16.PMID: 17234170 [PubMed - indexed for MEDLINE]Related articles

    12.

    IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.

    Yildiz B, Kural N, Colak O, Ak I, Akcar N.

    Clin Physiol Funct Imaging. 2008 Mar;28(2):107-12. Epub 2007 Dec 18.PMID: 18093232 [PubMed - indexed for MEDLINE]Related articles

    13.

    Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma.

    Lee KS, Min KH, Kim SR, Park SJ, Park HS, Jin GY, Lee YC.

    Am J Respir Crit Care Med. 2006 Jul 15;174(2):161-70. Epub 2006 Apr 27.PMID: 16645174 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Divergent effects of hyper- and hypoglycemia on circulating vascular endothelial growth factor in humans.

    Oltmanns KM, Melchert UH, Scholand-Engler HG, Schultes B, Schweiger U, Peters A.

    Metabolism. 2008 Jan;57(1):90-4.PMID: 18078864 [PubMed - indexed for MEDLINE]Related articles

    15.

    Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients.

    Ferretti G, Fabi A, Carlini P, Papaldo P, Cordiali Fei P, Di Cosimo S, Salesi N, Giannarelli D, Alimonti A, Di Cocco B, D'Agosto G, Bordignon V, Trento E, Cognetti F.

    Oncology. 2005;69(1):35-43. Epub 2005 Aug 2.PMID: 16088233 [PubMed - indexed for MEDLINE]Related articles

    16.

    Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC).

    Laack E, Scheffler A, Burkholder I, Boeters I, Andritzky B, Schuch G, Görn M, Vohwinkel G, Edler L, Fiedler W, Hossfeld DK.

    Lung Cancer. 2005 Oct;50(1):51-8.PMID: 15992959 [PubMed - indexed for MEDLINE]Related articles

    17.

    [The role of angiostatin, vascular endothelial growth factor, matrix metalloproteinase 9 and 12 in the angiogenesis of hepatocellular carcinoma]

    Kim S, Park HS, Son HJ, Moon WS.

    Korean J Hepatol. 2004 Mar;10(1):62-72. Korean. PMID: 15096718 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Hydrocortisone suppresses intranuclear activator-protein-1 (AP-1) binding activity in mononuclear cells and plasma matrix metalloproteinase 2 and 9 (MMP-2 and MMP-9).

    Aljada A, Ghanim H, Mohanty P, Hofmeyer D, Tripathy D, Dandona P.

    J Clin Endocrinol Metab. 2001 Dec;86(12):5988-91.PMID: 11739475 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.

    Adya R, Tan BK, Punn A, Chen J, Randeva HS.

    Cardiovasc Res. 2008 May 1;78(2):356-65. Epub 2007 Dec 18.PMID: 18093986 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Circulating mononuclear cells in the obese are in a proinflammatory state.

    Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P.

    Circulation. 2004 Sep 21;110(12):1564-71. Epub 2004 Sep 13.PMID: 15364812 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity